On the Path to Commercialization: HIT Fund Awardee Panel Discussion
Part of the Stanford HIT Fund - Lab to Market Seminar Series

Date: Friday, May 30, 2025
Time: 1 - 2 pm
Attendees: Stanford faculty, students, & staff only

Registration is required. A zoom link will be sent to all Stanford registrants.
Sign in to Google to save your progress. Learn more
Email *
Name *

Are you a Stanford innovator ready to transform your groundbreaking research into a thriving commercial endeavor? The HIT Fund is your proven partner for mapping a clear path from academic innovation to successful business launch. With an investment over our first two years of $2 million, the HIT Fund has enabled numerous Stanford innovators to license their technology and 19 teams to collectively raise over $35 million to date.

Leveraging the HIT Fund’s robust and customized commercialization support, including a tailored team of industry experts and a dedicated MBA Fellow acting as a hands-on business partner, HIT Fund awardees develop and execute on a “critical path” plan to navigate everything from identifying the best market for their technology to developing a compelling pitch for investors.

In this session, hear stories from current and former HIT Fund awardees on how they leveraged the fund's support to get their innovation from the lab to the market.


HIT Fund awardee panelists:

Katja Weinacht, Assistant Professor of Pediatrics, Stem Cell Transplantation and Regenerative Medicine

Dan C. Lee, CEO & Co-Founder, Perseus Materials - former Stanford postdoc

Maxim Zaslavsky, Entrepreneur - former Stanford postdoc


Learn more about the Stanford HIT Fund: goto.stanford.edu/HITfund
A copy of your responses will be emailed to the address you provided.
Submit
Clear form
Never submit passwords through Google Forms.
reCAPTCHA
This form was created inside of Stanford University.

Does this form look suspicious? Report